BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 19706711)

  • 21. Impaired processing and presentation of cytotoxic-T-lymphocyte (CTL) epitopes are major escape mechanisms from CTL immune pressure in human immunodeficiency virus type 1 infection.
    Yokomaku Y; Miura H; Tomiyama H; Kawana-Tachikawa A; Takiguchi M; Kojima A; Nagai Y; Iwamoto A; Matsuda Z; Ariyoshi K
    J Virol; 2004 Feb; 78(3):1324-32. PubMed ID: 14722287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of HLA-B57-restricted human immunodeficiency virus type 1 Gag- and RT-specific cytotoxic T lymphocyte responses.
    Klein MR; van der Burg SH; Hovenkamp E; Holwerda AM; Drijfhout JW; Melief CJ; Miedema F
    J Gen Virol; 1998 Sep; 79 ( Pt 9)():2191-201. PubMed ID: 9747728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load.
    Harrer T; Harrer E; Kalams SA; Barbosa P; Trocha A; Johnson RP; Elbeik T; Feinberg MB; Buchbinder SP; Walker BD
    J Immunol; 1996 Apr; 156(7):2616-23. PubMed ID: 8786327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How important is the 'quality' of the cytotoxic T lymphocyte (CTL) response in protection against HIV infection?
    Rowland-Jones SL; Pinheiro S; Kaul R; Hansasuta P; Gillespie G; Dong T; Plummer FA; Bwayo JB; Fidler S; Weber J; McMichael A; Appay V
    Immunol Lett; 2001 Nov; 79(1-2):15-20. PubMed ID: 11595285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A long-term follow-up of an HIV type 1-infected patient reveals a coincidence of Nef-directed cytotoxic T lymphocyte effectors and high incidence of epitope-deleted variants.
    Singh MK; Janvier G; Calvez V; Coulaud P; Rivière Y
    AIDS Res Hum Retroviruses; 2001 Sep; 17(13):1265-71. PubMed ID: 11559426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Most highly exposed seronegative men lack HIV-1-specific, IFN-gamma-secreting T cells.
    Hladik F; Desbien A; Lang J; Wang L; Ding Y; Holte S; Wilson A; Xu Y; Moerbe M; Schmechel S; McElrath MJ
    J Immunol; 2003 Sep; 171(5):2671-83. PubMed ID: 12928421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dendritic cell vaccination induces cross-reactive cytotoxic T lymphocytes specific for wild-type and natural variant human immunodeficiency virus type 1 epitopes in HLA-A*0201/Kb transgenic mice.
    Abdel-Motal UM; Friedline R; Poligone B; Pogue-Caley RR; Frelinger JA; Tisch R
    Clin Immunol; 2001 Oct; 101(1):51-8. PubMed ID: 11580226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease.
    Carmichael A; Jin X; Sissons P; Borysiewicz L
    J Exp Med; 1993 Feb; 177(2):249-56. PubMed ID: 8093890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pol-Driven Replicative Capacity Impacts Disease Progression in HIV-1 Subtype C Infection.
    Ojwach DBA; MacMillan D; Reddy T; Novitsky V; Brumme ZL; Brockman MA; Ndung'u T; Mann JK
    J Virol; 2018 Oct; 92(19):. PubMed ID: 29997209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple transmissions of a stable human leucocyte antigen-B27 cytotoxic T-cell-escape strain of HIV-1 in The Netherlands.
    Cornelissen M; Hoogland FM; Back NK; Jurriaans S; Zorgdrager F; Bakker M; Brinkman K; Prins M; van der Kuyl AC
    AIDS; 2009 Jul; 23(12):1495-500. PubMed ID: 19487902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD8(+) lymphocytes respond to different HIV epitopes in seronegative and infected subjects.
    Kaul R; Dong T; Plummer FA; Kimani J; Rostron T; Kiama P; Njagi E; Irungu E; Farah B; Oyugi J; Chakraborty R; MacDonald KS; Bwayo JJ; McMichael A; Rowland-Jones SL
    J Clin Invest; 2001 May; 107(10):1303-10. PubMed ID: 11375420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of HIV-1 specific T lymphocyte responses in highly exposed persistently seronegative Chinese.
    Liu HW; Hong KX; Ma J; Yuan L; Liu S; Chen JP; Zhang YZ; Ruan YH; Xu JQ; Shao YM
    Chin Med J (Engl); 2006 Oct; 119(19):1616-21. PubMed ID: 17042974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human immunodeficiency virus (HIV)-specific cytotoxic T lymphocyte activity in HIV-exposed seronegative persons.
    Bernard NF; Yannakis CM; Lee JS; Tsoukas CM
    J Infect Dis; 1999 Mar; 179(3):538-47. PubMed ID: 9952359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of a major histocompatibility complex class I-restricted cytotoxic T-lymphocyte response to a highly conserved region of human immunodeficiency virus type 1 (HIV-1) gp120 in seronegative humans immunized with a candidate HIV-1 vaccine.
    Johnson RP; Hammond SA; Trocha A; Siliciano RF; Walker BD
    J Virol; 1994 May; 68(5):3145-53. PubMed ID: 7908700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impaired replication capacity of acute/early viruses in persons who become HIV controllers.
    Miura T; Brumme ZL; Brockman MA; Rosato P; Sela J; Brumme CJ; Pereyra F; Kaufmann DE; Trocha A; Block BL; Daar ES; Connick E; Jessen H; Kelleher AD; Rosenberg E; Markowitz M; Schafer K; Vaida F; Iwamoto A; Little S; Walker BD
    J Virol; 2010 Aug; 84(15):7581-91. PubMed ID: 20504921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of the human env-specific cytotoxic T-lymphocyte (CTL) response in natural human immunodeficiency virus type 1 infection: low prevalence of broadly cross-reactive env-specific CTL.
    Carmichael A; Jin X; Sissons P
    J Virol; 1996 Dec; 70(12):8468-76. PubMed ID: 8970969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequent detection of escape from cytotoxic T-lymphocyte recognition in perinatal human immunodeficiency virus (HIV) type 1 transmission: the ariel project for the prevention of transmission of HIV from mother to infant.
    Wilson CC; Brown RC; Korber BT; Wilkes BM; Ruhl DJ; Sakamoto D; Kunstman K; Luzuriaga K; Hanson IC; Widmayer SM; Wiznia A; Clapp S; Ammann AJ; Koup RA; Wolinsky SM; Walker BD
    J Virol; 1999 May; 73(5):3975-85. PubMed ID: 10196293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human immunodeficiency virus type 1 specific cytotoxic T lymphocyte responses in Chinese infected with HIV-1 B'/C Recombinant (CRF07_BC).
    Chen J; Hong K; Jia M; Liu H; Zhang Y; Liu S; Zhang X; Zhao H; Peng H; Ma P; Xing H; Ruan Y; Williams KL; Yu XG; Altfeld M; Walker BD; Shao Y
    Retrovirology; 2007 Aug; 4():62. PubMed ID: 17727734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HLA Class I Downregulation by HIV-1 Variants from Subtype C Transmission Pairs.
    Ende Z; Deymier MJ; Claiborne DT; Prince JL; Mónaco DC; Kilembe W; Allen SA; Hunter E
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29321314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with rgp120 elicits broad and durable CD8+ cytotoxic T lymphocyte responses in seronegative volunteers.
    Evans TG; Keefer MC; Weinhold KJ; Wolff M; Montefiori D; Gorse GJ; Graham BS; McElrath MJ; Clements-Mann ML; Mulligan MJ; Fast P; Walker MC; Excler JL; Duliege AM; Tartaglia J
    J Infect Dis; 1999 Aug; 180(2):290-8. PubMed ID: 10395842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.